<DOC>
	<DOCNO>NCT02532153</DOCNO>
	<brief_summary>Every 40 second , someone world die suicide . There lack effective safe antisuicidal agent prevent suicide attempt . This lead immense worldwide individual , financial , societal burden suicide—which project rise come decades—supporting need antisuicidal treatment . This treatment gap may fill understand neurobiology suicide , guide development target antisuicidal treatment . Though research examine neurobiology suicidal ideation context depression—implicating orbital frontal cortex , anterior cingulate cortex , striatum—the underlie pathophysiology neurobiology suicidal ideation separate construct depression remain largely unknown . Therefore , investigator propose study neurocircuitry suicidal thought , regardless whether depression present .</brief_summary>
	<brief_title>The Impact Ketamine Reward Circuitry Suicidal Patients</brief_title>
	<detailed_description />
	<mesh_term>Suicide</mesh_term>
	<mesh_term>Suicidal Ideation</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Patients : 1. ≥18 year old , 2. read , understand , provide write informed consent , 3. suicidal ideation ≥ 2 month , per Columbia Suicide Severity Rating Scale ( CSSRS ) , 4. stable psychiatric medication regimen ≥28 day , 5. maintain treat doctor agreement study participation , aware safety plan protocol , 6. reliable chaperone accompany home follow completion ketamine infusion day , 7. generally healthy , assessed medical history , physical examination ( include vital sign ) , clinical laboratory evaluation , electrocardiogram ( EKG ) , 8. nonchildbearing potential use acceptable form birth control ( female ) , 9. right hand . Healthy Controls : 1. ≥18 year old , 2. read , understand , provide write informed consent , 3. negative pregnancy test morning MRI ( female ) . 4. right hand . Patients exclude follow criterion meet : 1. delirium dementia diagnosis , 2. unstable medical illness clinically significant laboratory result , 3. history clinically significant cardiovascular disease electrocardiogram ( EKG ) finding , medical condition put patient risk possible cardiac side effect alter brain morphology ( e.g. , diabetes , hypertension , traumatic brain injury ) , even well controlled medication , 4. history multiple adverse drug reaction , 5. active substance use disorder ( except nicotine caffeine ) within past six month , positive urine toxicology screen , past history ketamine/PCP abuse , 6. requirement exclude medication may interact ketamine ( e.g. , narcotic , barbiturate , sedative , theophylline , St. John 's Wort ) , 7 . BMI &gt; 35 , 8. pregnancy , breastfeeding , unacceptable mean birth control ( female ) 9. presence MRI contraindication ( e.g. , presence metallic ( ferromagnetic ) implant ( e.g. , heart pacemaker , aneurysm clip ) ) , 10. concurrent participation research study . Healthy control exclude follow criterion meet : 1. current past Axis I diagnosis , include alcohol substance abuse dependence diagnosis ( except nicotine caffeine ) suicidal thoughts/attempts , 2. presence MRI contraindication ( e.g. , presence metallic ( ferromagnetic ) implant ( e.g. , heart pacemaker , aneurysm clip ) ) , 3. presence medical illness likely alter brain morphology and/or physiology ( e.g. , diabetes ) even control medication , 4. requirement exclude medication may interact ketamine ( e.g. , narcotic , barbiturate , benzodiazepine , sedative , theophylline , St. John 's Wort ) , 5. presence psychiatric disorder firstdegree relative , 6. pregnancy , breastfeeding , unacceptable mean birth control ( female ) , 7 . BMI &gt; 35 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Suicidal Ideation</keyword>
	<keyword>Suicide</keyword>
	<keyword>Suicidal Thoughts</keyword>
	<keyword>Depression</keyword>
	<keyword>Ketamine</keyword>
</DOC>